These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22762712)

  • 1. Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Vasaiwala S; Vlachos H; Selzer F; Marroquin O; Mulukutla S; Abbott JD; Williams DO
    Am J Cardiol; 2012 Oct; 110(8):1113-8. PubMed ID: 22762712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.
    Parikh SV; Luna M; Selzer F; Marroquin OC; Mulukutla SR; Abbott JD; Holper EM
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):192-200. PubMed ID: 21735515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).
    Parikh SV; Saya S; Divanji P; Banerjee S; Selzer F; Abbott JD; Naidu SS; Wilensky RL; Faxon DP; Jacobs AK; Holper EM
    Am J Cardiol; 2011 Apr; 107(7):959-64. PubMed ID: 21256469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
    J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Abbott JD; Vlachos HA; Selzer F; Sharaf BL; Holper E; Glaser R; Jacobs AK; Williams DO;
    Am J Cardiol; 2007 Mar; 99(5):626-31. PubMed ID: 17317361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Bainey KR; Selzer F; Cohen HA; Marroquin OC; Holper EM; Graham MM; Williams DO; Faxon DP
    Am J Cardiol; 2012 Jan; 109(2):195-201. PubMed ID: 22000774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Bangalore S; Vlachos HA; Selzer F; Wilensky RL; Kip KE; Williams DO; Faxon DP
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):22-8. PubMed ID: 20506328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents.
    Ferenc M; Gick M; Kienzle RP; Bestehorn HP; Werner KD; Comberg T; Zhao M; Buettner HJ; Neumann FJ
    Am Heart J; 2010 Mar; 159(3):454-61. PubMed ID: 20211309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Mulukutla SR; Vlachos HA; Marroquin OC; Selzer F; Holper EM; Abbott JD; Laskey WK; Williams DO; Smith C; Anderson WD; Lee JS; Srinivas V; Kelsey SF; Kip KE
    JACC Cardiovasc Interv; 2008 Apr; 1(2):139-47. PubMed ID: 19212456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can intravascular ultrasound guidance modify the efficacy of drug-eluting stent over bare-metal stent in an aorto-ostial lesion?
    Okabe T; Kawamura A; Maekawa Y; Anzai T; Iwanaga S; Yoshikawa T; Ogawa S
    Cardiovasc Revasc Med; 2011; 12(2):105-10. PubMed ID: 21421189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.
    Venkitachalam L; Kip KE; Selzer F; Wilensky RL; Slater J; Mulukutla SR; Marroquin OC; Block PC; Williams DO; Kelsey SF;
    Circ Cardiovasc Interv; 2009 Feb; 2(1):6-13. PubMed ID: 20031687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of bare-metal and drug-eluting stents for off-label indications.
    Marroquin OC; Selzer F; Mulukutla SR; Williams DO; Vlachos HA; Wilensky RL; Tanguay JF; Holper EM; Abbott JD; Lee JS; Smith C; Anderson WD; Kelsey SF; Kip KE
    N Engl J Med; 2008 Jan; 358(4):342-52. PubMed ID: 18216354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents.
    Tsagalou E; Stankovic G; Iakovou I; Melzi G; Cosgrave J; Ge L; Michev I; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
    Am J Cardiol; 2006 Jan; 97(2):187-91. PubMed ID: 16442360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
    Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
    Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug-eluting and bare metal stents in large coronary arteries: findings from the NHLBI dynamic registry.
    Chan CY; Vlachos H; Selzer F; Mulukutla SR; Marroquin OC; Abbott DJ; Holper EM; Williams DO
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):24-9. PubMed ID: 24323698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy.
    Tremmel JA; Ng MK; Ikeno F; Hunt SA; Lee DP; Yeung AC; Fearon WF
    Am J Cardiol; 2011 Sep; 108(5):665-8. PubMed ID: 21684511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.